Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income $ 31,977 $ 35,701
Adjustments to reconcile net income to net cash provided by operating activities:    
(Income) loss from discontinued operations (108) 924
Depreciation and amortization 11,545 10,783
Deferred income taxes (5,315) 1,146
Non-cash equity based compensation 5,633 4,495
Change in assets and liabilities:    
Accounts receivable - billed 7,268 (1,596)
Accounts receivable - unbilled (63) 2,021
Prepaid expenses and other current assets (4,092) 1,669
Deferred contract costs 1,109 (1,229)
Accounts payable 12,298 12,287
Accrued compensation and benefits (6,287) (6,567)
Deferred revenue 11,291 (11,296)
Income taxes 8,910 (10,334)
Other assets and liabilities (5,128) (1,618)
Cash provided by operating activities - continuing operations 69,038 36,386
Cash used in operating activities - discontinued operations   (951)
Cash provided by operating activities 69,038 35,435
Cash flows from investing activities:    
Proceeds from sale of discontinued operations 2,240  
Proceeds from note receivable 272  
Purchases of property and equipment (6,576) (6,464)
Capitalized software costs (1,832) (3,872)
Cash used in investing activities - continuing operations (5,896) (10,336)
Cash used in investing activities (5,896) (10,336)
Cash flows from financing activities:    
Employee stock transactions 1,687 8,013
Repurchases of common stock (9,749) (8,459)
Tax benefit due to option exercises and restricted stock units vesting 2,510 3,818
Issuance of long-term debt   300
Cash dividends paid (6,061) (4,643)
Cash used in financing activities - continuing operations (11,613) (971)
Cash used in financing activities (11,613) (971)
Effect of exchange rate changes on cash and cash equivalents 5,058 3,706
Net increase in cash and cash equivalents 56,587 27,834
Cash and cash equivalents, beginning of period 172,950 155,321
Cash and cash equivalents, end of period $ 229,537 $ 183,155